MARKET

MCRPF

MCRPF

Microport Scien
OTCPK

Real-time Quotes | Nasdaq Last Sale

1.960
+0.280
+16.67%
Closed 16:00 06/24 EDT
OPEN
--
PREV CLOSE
1.960
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
9.30
52 WEEK LOW
1.680
MARKET CAP
3.57B
P/E (TTM)
-2.1297
1D
5D
1M
3M
1Y
5Y
BRIEF-Microport Scientific Posts Qtrly Net Profit Attributable Of Shanghai Microport Endovascular Medtech RMB123.5 Mln
reuters.com · 04/29 13:42
BRIEF-Microport Scientific Posts FY Net Profit Attributable For Microport Endovascular Medtech RMB315.9 Million
reuters.com · 03/29 15:16
BRIEF-Microport Scientific Says For Year Recorded Loss Attributable Of Between $275 Mln - $285 Mln
reuters.com · 03/04 15:07
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea. The devices are equipped with Bluetoo...
PR Newswire · 01/17 04:18
BRIEF-Microport Scientific Proposes To Spin Off Shares Of Microport Neurotech
reuters.com · 12/28/2021 15:03
BRIEF-Microport Scientific Announces Investment In Microport Neurotech Limited
reuters.com · 11/11/2021 01:06
BRIEF-Microport Scientific Says Unit Entered Into Equity Transfer And Capital Increase Agreement
reuters.com · 10/29/2021 13:18
BRIEF-Microport Scientific Updates On Proposed Spin-Off & Separate Listing Of Shanghai Microport Medbot
reuters.com · 10/21/2021 00:51
More
No Data
Learn about the latest financial forecast of MCRPF. Analyze the recent business situations of Microport Scien through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

42.86%Strong Buy
28.57%Buy
28.57%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MCRPF stock price target is 4.166 with a high estimate of 7.39 and a low estimate of 2.166.
High7.39
Average4.166
Low2.166
Current 1.960
EPS
Actual
Estimate
0.030.050.070.10
Q1 2009
Q1 2010
Institutional Holdings
Institutions: 2
Institutional Holdings: 857.26K
% Owned: 0.05%
Shares Outstanding: 1.82B
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.64%
Healthcare Equipment & Supplies
+2.14%
Key Executives
Chairman/Chief Executive Officer/Executive Director
Zhaohua Chang
Chief Financial Officer
Hongbin Sun
Corporate Executive
Benoit Clinchamps
Corporate Executive
Benny Hagag
Corporate Executive
Lei Jiang
Chief Operating Officer
Glendy Wang
Chief Technology Officer
Qiyi Luo
Other
Jonathan Chen
Other
Yue Chengyun
Other
Linda Lin
Other
Bo Peng
Other
Todd Smith
Other
Paul Vodden
Other
Philippe Wanstok
Other
Xu Yimin
Other
Que Yiyun
Other
Xiaoming Zhu
Secretary
Wing Yan Winnie Yuen
Non-Executive Director
Norihiro Ashida
Non-Executive Director
Yu Hongliang
Non-Executive Director
Yasuhisa Kurogi
Non-Executive Independent Director
Jonathan Chou
Non-Executive Independent Director
Guoen Liu
Non-Executive Independent Director
Chunyang Shao
No Data
No Data
About MCRPF
MicroPort Scientific Corporation is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of medical products. The Company operates through seven segments. Orthopedics Devices segment researches, develops, manufactures and sells orthopedics devices. Cardiovascular Devices segment researches, develops, manufactures and sells cardiovascular devices, such as drug eluting stents. Endovascular Devices segment researches, develops, manufactures and sells endovascular devices. Electrophysiology Devices segment researches, develops, manufactures and sells electrophysiology devices. Neurovascular Devices segment researches, develops, manufactures and sells neurovascular devices. Surgical Management segment researches, develops, manufactures and sells surgical devices. Diabetes Care and Endocrinal Management segment researches, develops, manufactures and sells devices related to diabetes mellitus.

Webull offers kinds of MicroPort Scientific Corporation stock information, including OTCPK:MCRPF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MCRPF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MCRPF stock methods without spending real money on the virtual paper trading platform.